Naltrexone induces down- and upregulation of δ opioid receptors in rat brain regions (original) (raw)
Chronic opioid antagonist treatment: assessment of receptor upregulation
VICTOR SIERRA
European Journal of Pharmacology, 1989
View PDFchevron_right
Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects
semi helin
Neuropsychopharmacology, 2019
View PDFchevron_right
Paradoxical and subtype-specific effects of opiate antagonists on the expression of opioid receptors in rat brain cultures
Jacob Barg
Journal of Neuroscience Research, 1989
View PDFchevron_right
effect of α-adrenergic blockers on naloxone-binding in braiN
Theodore Cicero
Biochemical Pharmacology, 1974
View PDFchevron_right
Convulsant action of naloxone in the rat amygdala
Zuner A Bortolotto
NIDA research monograph
View PDFchevron_right
Receptor-selective changes in u-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice
Ian Kitchen
European Journal of Neuroscience, 2003
View PDFchevron_right
Quantitative immunolocalization of mu opioid receptors: regulation by naltrexone
Hoa Lam
Neuroscience, 1998
View PDFchevron_right
Combined autoradiographic-immunocytochemical analysis of opioid receptors and opioid peptide neuronal systems in brain
Henry Khachaturian
Peptides, 1985
View PDFchevron_right
Buprenorphine differentially alters opioid receptor adaptation in rat brain regions
Jacob Barg
The Journal of pharmacology and experimental therapeutics, 1996
View PDFchevron_right
Is there tonic activity in the endogenous opioid systems? A c-Fos study in the rat central nervous system after intravenous injection of naloxone or naloxone-methiodide
Christian Gestreau
The Journal of Comparative Neurology, 2000
View PDFchevron_right
Opioid pharmacology in the rat hippocampal slice
Raymond Dingledine
Life Sciences, 1982
View PDFchevron_right
Quaternary naltrexone reveals the central mediation of conditional opioid analgesia
Daniel Calcagnetti
Pharmacology Biochemistry and Behavior, 1987
View PDFchevron_right
Differential Activation and Trafficking of �-Opioid Receptors in Brain Slices
Seksiri Arttamangkul, John Pintar
Mol Pharmacol, 2008
View PDFchevron_right
Opioid P Eptides a ND T Heir Receptors: O Verview a ND Function I N P Ain M Odulation
Salu Jose
View PDFchevron_right
Regional saturation studies of [3H]naloxone binding in the naive, dependent and withdrawal states
William Geary
Brain Research, 1985
View PDFchevron_right
Chronic morphine and naltrexone fail to modify μ-opioid receptor mRNA levels in the rat brain
Giacomo Diaz
Molecular Brain Research, 1997
View PDFchevron_right
Naltrexone in vivo protects μ receptors from inactivation by β-funaltrexamine, but not κ receptors from inactivation by nor-binaltorphimine
C. Paronis
Pharmacology Biochemistry and Behavior, 1993
View PDFchevron_right
Reassessment of opioid binding sites in the rat brain
Noureddine Bourhim
Neuropeptides, 1986
View PDFchevron_right
Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors
Maria Concetta Olianas
British Journal of Pharmacology, 2006
View PDFchevron_right
An analysis of naltrexone and naloxone's possible agonistic action in the dog
Joseph Wettstein
View PDFchevron_right
Basal Signaling Activity of Opioid Receptor in Mouse Brain: Role in Narcotic Dependence
Edward Bilsky
Journal of Pharmacology and Experimental Therapeutics, 2003
View PDFchevron_right
Naloxone’s displacement of [11C]carfentanil and duration of receptor occupancy in the rat brain: implications for opioid overdose reversal
Yeona Kang
2022
View PDFchevron_right
Reversal of morphine-induced catalepsy by naloxone microinjections into brain regions with high opiate receptor binding: A preliminary report
Michael Bozarth
Pharmacology Biochemistry and Behavior, 1983
View PDFchevron_right
Brain opioid receptor binding in early abstinence from opioid dependence
Mark Daglish
The British Journal of …, 2007
View PDFchevron_right
Agonist-specific down regulation of mu-opioid receptors: Different cellular pathways are activated by different opioid agonists
Yosef Sarne
Life Sciences, 2008
View PDFchevron_right
Pharmacological and anatomical evidence of selective μ, δ, and χ opioid receptor binding in rat brain
Stan Watson
Brain Research, 1986
View PDFchevron_right
Clorazepate affects cell surface regulation of δ and κ opioid receptors, thereby altering buprenorphine-induced adaptation in the rat brain
Antoine Coquerel
Brain Research, 2005
View PDFchevron_right
Mechanisms of Agonist-Induced Down-Regulation of the Human κ-Opioid Receptor: Internalization Is Required for Down-Regulation
Jeffrey Benovic
Molecular Pharmacology, 2000
View PDFchevron_right
Dissociation of opioid receptor upregulation and functional supersensitivity
victor garcia sierra
Pharmacology Biochemistry and Behavior, 1991
View PDFchevron_right
Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system
A. C Civelek
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997
View PDFchevron_right
The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine
Fishman Jordan
Life Sciences, 1993
View PDFchevron_right
Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice
Anders Agmo
European Journal of Pharmacology, 1997
View PDFchevron_right
Chronic administration of morphine and naltrexone up-regulate μ-opioid binding sites labeled by [3H][D-Ala2, MePhe4, Gly-ol5]enkephalin: further evidence for two μ-binding sites
Kenner Rice
European Journal of Pharmacology, 1989
View PDFchevron_right
Naloxone’s dose-dependent displacement of [11C]carfentanil and duration of receptor occupancy in the rat brain
Yeona Kang
Scientific Reports
View PDFchevron_right
Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine
Jacob Barg
Molecular Pharmacology, 1993
View PDFchevron_right